What is Sensome?
Sensome specializes in leveraging impedance-based micro-sensors combined with machine learning to create sophisticated remote monitoring systems. Their core innovation lies in accurately identifying biological tissues, with their flagship product being the Clotild connected guidewire, designed for the treatment of ischemic stroke. The company's technology holds considerable promise for broader applications across various medical fields, including oncology and the treatment of peripheral artery disease. Sensome's international team comprises a diverse group of experts in multiple medical disciplines, augmented by experienced MedTech entrepreneurs and academics.
How much funding has Sensome raised?
Sensome has raised a total of $14.6M across 2 funding rounds:
Unspecified
$5.6M
Series B
$9M
Unspecified (2018): $5.6M with participation from KURMA PARTNERS and BNP Paribas Développement
Series B (2020): $9M led by Kurma Partners, Asahi Intecc Co., Paris-Saclay Seed Fund, BNP Paribas Développement, and Idinvest Partners
Key Investors in Sensome
Kurma Partners
Kurma Partners is a venture capital firm focused on funding healthcare and biotechnology companies, specializing in transforming scientific discoveries into advanced medical solutions for severe diseases.
Idinvest Partners
Idinvest Partners is a mid-market private equity firm that finances and supports entrepreneurs throughout their business development stages, with a strong presence in France.
Asahi Intecc Co.
Asahi Intecc Co. is an investor participating in the funding round, contributing to Sensome's growth in the medical technology sector.
What's next for Sensome?
The substantial enterprise-level funding indicates Sensome is poised for significant scaling and market penetration. The recent strategic investment suggests a focus on accelerating product development, expanding clinical trials, and forging key partnerships within the healthcare ecosystem. Future growth is likely to involve further refinement of their core sensor technology and the commercialization of their connected guidewire, potentially leading to new product lines addressing other critical medical needs.
See full Sensome company page
